Antineoplastic CAS 1420477-60-6 Acalabrutinib Powder Price Acalabrutinib Powder Raw Material Acalabrutinib

China Antineoplastic CAS 1420477-60-6 Acalabrutinib Powder Price Acalabrutinib Powder Raw Material Acalabrutinib, Find details about China Acalabrutinib, Acalabrutinib Powder from Antineoplastic CAS 1420477-60-6 Acalabrutinib Powder Price Acalabrutinib Powder Raw Material Acalabrutinib

Basic Info.

Model NO.

D-Sung Acalabrutinib

Product Name

Acalabrutinib

Name

Acalabrutinib Powder

Appearance

White Crystalline Powder

Color

White

Store

Cool and Dry

Grade

Pharmaceutical Grade

Assay

HPLC 99%

Application

Anthelmintics

Specific

COA

Test Method

HPLC

Shelf Life

2 Years

CAS No.

1420477-60-6

C26h23n7o2

Desnity

1.37-0.1 g/cm3

465.51

Trademark

D-Sung

Transport Package

Negotiable

Specification

99%

Origin

Xi′an Shaanxi

Model NO.

D-Sung Acalabrutinib

Product Name

Acalabrutinib

Name

Acalabrutinib Powder

Appearance

White Crystalline Powder

Color

White

Store

Cool and Dry

Grade

Pharmaceutical Grade

Assay

HPLC 99%

Application

Anthelmintics

Specific

COA

Test Method

HPLC

Shelf Life

2 Years

CAS No.

1420477-60-6

C26h23n7o2

Desnity

1.37-0.1 g/cm3

465.51

Trademark

D-Sung

Transport Package

Negotiable

Specification

99%

Origin

Xi′an Shaanxi

Product Desciption

Antineoplastic CAS 1420477-60-6 Acalabrutinib Powder Price Acalabrutinib Powder Raw Material Acalabrutinib

Antineoplastic CAS 1420477-60-6 Acalabrutinib Powder Price Acalabrutinib Powder Raw Material Acalabrutinib

Product Name	Acalabrutinib
Appearance	White crystalline powder
CAS No.	1420477-60-6
MF	C26H23N7O2

Acalabrutinib is a novel anti-cancer drug and a second generation Bruton's tyrosine kinase (BTK) inhibitor developed by Acerta Pharma. It is more potent and selective (fewer side-effects) than ibrutinib, the first-in-class BTK inhibitor. In October 2017, the Food and Drug Administration approved the drug for treatment of mantle cell lymphoma in patients who had previously been treated with another therapy.

Antineoplastic CAS 1420477-60-6 Acalabrutinib Powder Price Acalabrutinib Powder Raw Material Acalabrutinib Acalabrutinib (ACP-196) is an orally active, irreversible, and highly selective second-generation BTK inhibitor. Acalabrutinib binds covalently to Cys481 in the ATP-binding pocket of BTK. Acalabrutinib demonstrates potent on-target effects and efficacy in mouse models of chronic lymphocytic leukemia (CLL).